Search Results
Slidesets
How Stigma is Impacting the 90-90-90 Goals - Mauro Schechter
Presented at:
Latin American Stigma & Discrimination Forum 2020
Slidesets
Abstract #7 Pre-Exposure Prophylaxis Among a Cohort of Cis and Transgender Female Sex Workers in Buenos Aires, Argentina: Not All Women Are the Same - Valeria Irene Fink
Presented at:
15th International Workshop on Women & HIV 2025
Slidesets
Impact of COVID-19 on Transgender Communities Globally - Andreas Koehler
Presented at:
International Workshop on HIV and Transgender People 2020
Slidesets
The use of DAA’s in pregnancy in HCV infected mothers- David Burger, PharmD, PhD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018
Slidesets
Insights and Lessons Learned on Retention, Adherence, and Achieving and Maintaining Viral Suppression: The Third 90 | Tsitsi Apollo
Presented at:
INTEREST 2016
Slidesets
Option B+: Beyond ART – Experience with Retention and Outcomes | Landon Myer
Presented at:
International Workshop on HIV & Pediatrics 2016
Slidesets
(Abstract) HBsAg immune-escape Mutations and Stop-Codons, Circulating among European HBV-chronically infected patients can impact on HBV transmission and disease progression | Dr. L. Colagrossi
Presented at:
European Meeting on HIV & Hepatitis 2016
Slidesets
Pediatric Treatment Cascade: What Do We Need to Reach “90‐90‐90” for Children - Elaine Abrams, MD
Presented at:
International Workshop on HIV & Pediatrics 2015
Slidesets
(Abstract) Cost-efficiency versus Potency | Anca Streinu-Cercel, MD, PhD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2016
Slidesets
Optimizing Clinical Utility of Integrase Inhibitors- Anton Pozniak, MD, FRCP
Presented at:
Global HIV Clinical Forum 2017